関連する実験動画
Updated: Feb 12, 2026

08:19
The Mouse Isolated Perfused Kidney Technique
Published on: November 17, 2016
23.4K
ネズミ の 腎臓 の 単細胞 転写 解析 は,腎臓 疾患 の 細胞 標的 の 可能性 を 明らかに し て い ます
Jihwan Park1, Rojesh Shrestha1, Chengxiang Qiu1
1Renal Electrolyte and Hypertension Division, Department of Medicine and Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.
まとめ
マウスの腎臓の単細胞RNA配列解析は,遺伝性腎臓疾患の細胞型の起源を明らかにする. 採集管内の新たに特定された移行細胞は細胞運命を影響し,腎臓疾患における代謝性酸性症に関連しています.
科学分野:
- 腎臓科
- 分子生物学
- 遺伝学
背景:
- 腎臓病の病原性は,腎臓細胞の分子特徴が限られているため,十分に理解されていません.
- 腎臓のホメオスタシスに関与する細胞タイプを特定することは,病気のメカニズムを理解するために不可欠です.
研究 の 目的:
- 単細胞RNA配列解析を用いて,健康なマウスの腎臓の細胞タイプを分子的に特徴づける.
- 遺伝性腎臓疾患の細胞起源を調査し,腎臓機能と疾患に関与する新しい細胞タイプと経路を特定する.
主な方法:
- 健康なマウスの腎臓からの57,979の細胞の偏らない単細胞RNA配列化.
- 計算による細胞経路分析と in vivo 系統追跡
主要な成果:
- 遺伝子発現パターンは,類似した現象型が異なる変異を持つ腎臓疾患の共通の細胞型起源を示唆する.
- 成人マウスの採集管にある新しい移行細胞は 多様な細胞タイプを生成します
- Notchシグナル伝達によって媒介されるインターカレートおよび主要細胞移行は,代謝性アシドーシスと相関する腎臓疾患における主要な細胞運命にシフトする.
結論:
- この研究は,健康なマウスの腎臓の包括的な単細胞アトラスを提供し,腎臓疾患の細胞タイプ特有の起源を明らかにします.
- 新たに特定された移行細胞とノッチ信号伝達経路は,収集管内の細胞運命を決定する重要なレギュレーターです.
- 腎臓疾患における細胞運命を変化させた移行は,代謝性アシドーシスと関連しており,潜在的な治療目標を提供している.
関連する概念動画
Kidney Structure
75.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.5K
Chronic Kidney Disease I: Introduction
766
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
Chronic Kidney Disease II: Clinical Manifestations
683
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683
Chronic Kidney Disease III: Interprofessional Care
485
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
485
Chronic Kidney Disease IV: Nursing Management
413
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
413
Kidney Transplant I: Introduction
498
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
498

